You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 1, January 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (146)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Double-blind Comparison of Amantadine and Bromocriptine for Ambulatory Withdrawal From Cocaine Dependence

Forest S. Tennant, Jr, MD, DrPH; Artin A. Sagherian, MD

Arch Intern Med. 1987;147(1):109-112.


Abstract

• Amantadine hydrochloride and bromocriptine mesylate were compared on a double-blind basis for withdrawal from cocaine dependence. Both amantadine and bromocriptine appear effective in alleviating the symptoms of cocaine withdrawal. In doses higher than previously reported, however, bromocriptine caused enough side effects to produce treatment dropouts; neither drug produced euphoria. Amantadine appears to primarily exert Its therapeutic Influence by releasing dopamine and norepinephrine from neuronal storage sites that are depleted by chronic cocaine dependence, and bromocriptine acts as a dopamine agonist and stimulates dopamine receptors.

(Arch Intern Med 1987;147:109-112)



Author Affiliations

From the School of Public Health, UCLA Center for Health Sciences (Dr Tennant) and the Community Health Projects Inc, Research and Education Division, West Covina, Calif (Drs Tennant and Sagherian).


Footnotes

Accepted for publication May 12,1986.

Reprint requests to Community Health Projects Inc, 3361/2 S Glendora Ave, West Covina, CA 91790 (Dr Tennant).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

From the Cover: Treating cocaine addiction with viruses
Carrera et al.
Proc. Natl. Acad. Sci. USA 2004;101:10416-10421.
ABSTRACT | FULL TEXT  

Amantadine in the Treatment of Cocaine-Dependent Patients With Severe Withdrawal Symptoms
Kampman et al.
Am. J. Psychiatry 2000;157:2052-2054.
ABSTRACT | FULL TEXT  

Parkinsonism Associated With Long-term Cocaine Abuse
Domingo and Martinez
Arch Intern Med 1997;157:241-241.
ABSTRACT  

Management of Cocaine Abuse and Dependence
Mendelson and Mello
NEJM 1996;334:965-972.
FULL TEXT  

Pharmacotherapy for Cocaine-Abusing Methadone-Maintained Patients Using Amantadine or Desipramine
Kosten et al.
Arch Gen Psychiatry 1992;49:894-898.
ABSTRACT  

New Pharmacotherapies for Cocaine Dependence... Revisited
Meyer
Arch Gen Psychiatry 1992;49:900-904.
ABSTRACT  

Desipramine Facilitation of Initial Cocaine Abstinence
Gawin et al.
Arch Gen Psychiatry 1989;46:117-121.
ABSTRACT  

Amantadine, Fatigue, and Multiple Sclerosis
Rosenberg and Appenzeller
Arch Neurol 1988;45:1104-1106.
ABSTRACT  

A second-generation vaccine protects against the psychoactive effects of cocaine
Carrera et al.
Proc. Natl. Acad. Sci. USA 2001;98:1988-1992.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.